TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance 

TCT 470: Novel Method for Implantation of Balloon Expandable Transcatheter Aortic Valve Replacement to Reduce Pacemaker Rate - Line of Lucency Method

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

TCT 475: In Tavi the Less Antibiotics, the Better!

TCT 474: Incidence and Impact of Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry

TCT 479: Rate of Temporary Pacing in Patients Developing New Left Bundle Branch Block During Transcatheter Aortic Valve Replacement

TCT 461: Predictors of Reversibility of Left Bundle Branch Block After TAVI Implantation

TCT 471: A Novel Computed Tomographic Angiography Tortuosity Index to Predict Successful Sentinel Cerebral Embolic Protection Delivery for Transcatheter Aortic Valve Replacement  

TCT 485: Do Manufacturer's Derived Recommendations Predict  Vascular Complications During Transfemoral TAVI  Approaches Using Default Proglide Strategy?